KLRK1 and neoplasm: The data showed that NKG2D-CAR-NK92 cells with GPR116 receptor knockdown released more cytotoxic substances such as GzmB and IFNγ, and suppressed tumor growth more effectively both in vitro and in vivo compared to NKG2D-CAR-NK92 cells.